SAB Biotherapeutics Inc. is an innovative biopharmaceutical company focused on the development of advanced immunotherapies targeting infectious diseases, autoimmune disorders, and cancer. Headquartered in Sioux Falls, South Dakota, with additional operations in Cambridge, Massachusetts, the company leverages its proprietary platform to produce fully human therapeutic antibodies from genetically engineered cows. This unique technology positions SAB Biotherapeutics at the forefront of addressing significant health challenges and delivering groundbreaking treatments in areas with considerable unmet medical needs, affirming its status as a key player in the biotherapeutics industry. Show more
Location: 777 W 41ST ST., MIAMI BEACH, FL, UNITED STATES, 33140, Miami Beach, FL, 33140, USA | Website: https://www.sabbiotherapeutics.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE
Market Cap
209M
52 Wk Range
$1.00 - $4.68
Previous Close
$4.39
Open
$4.41
Volume
522,971
Day Range
$4.34 - $4.68
Enterprise Value
105.7M
Cash
29.42M
Avg Qtr Burn
-13.05M
Insider Ownership
12.36%
Institutional Own.
69.90%
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
SAB-142 Details Stage 3 Type 1 Diabetes (T1D) | Phase 2b Data readout |
